Cargando…

The expression and clinical significance of PLK1/p-PLK1 protein in NK/T cell Lymphoma

AIMS: To investigate the expression of polo-like kinase 1 protein (PLK1) and its phosphorylation level (p-PLK1) in extranodal NK/T cell lymphoma (NKTCL) and their correlation with clinical characteristics and prognosis. METHODS: We collected 40 cases of NKTCL (referred to as the experimental group),...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhiqi, Liu, Enjie, Zhang, Dandan, Zhao, Wugan, Wang, Guannan, Zhang, Yanping, Huo, Yajun, Zhang, Chongli, Li, Wencai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691161/ https://www.ncbi.nlm.nih.gov/pubmed/38037110 http://dx.doi.org/10.1186/s13000-023-01413-w

Ejemplares similares

GNAQ T96S mutation abrogates the ability of wild‐type GNAQ to induce apoptosis by phosphorylating annexin A2 in natural killer/T cell lymphoma
por: Zhao, Wugan, et al.
Publicado: (2022)

HNF1A-AS1 promotes growth and metastasis of esophageal squamous cell carcinoma by sponging miR-214 to upregulate the expression of SOX-4
por: Wang, Guannan, et al.
Publicado: (2021)

Icaritin inhibits PLK1 to activate DNA damage response in NK/T cell lymphoma and increases sensitivity to GELOX regime
por: Zhang, Canjing, et al.
Publicado: (2022)

Clinicopathological Significance of AKT1 and PLK1 Expression in Oral Squamous Cell Carcinoma
por: Sun, Er-Can, et al.
Publicado: (2022)

Co‐Targeting Plk1 and DNMT3a in Advanced Prostate Cancer
por: Zhang, Zhuangzhuang, et al.
Publicado: (2021)

Co‐Targeting Plk1 and DNMT3a in Advanced Prostate Cancer
por: Zhang, Zhuangzhuang, et al.
Publicado: (2022)

Self-regulated mechanism of Plk1 localization to kinetochores: lessons from the Plk1-PBIP1 interaction
por: Lee, Kyung S, et al.
Publicado: (2008)

Plk1 in Asthma: Ready for Primetime?
por: Tam, John Kit Chung, et al.
Publicado: (2021)

Role of Polo-like Kinases Plk1 and Plk4 in the Initiation of Centriole Duplication—Impact on Cancer
por: Hoffmann, Ingrid
Publicado: (2022)

Comprehensive Analysis of the Expression and Prognosis for E2Fs in Human Clear Cell Renal Cell Carcinoma
por: Zhang, Chongli, et al.
Publicado: (2021)

Comprehensive analysis of differentially expressed genes associated with PLK1 in bladder cancer
por: Zhang, Zhe, et al.
Publicado: (2017)

The expression of PLK-1 in cervical carcinoma: a possible target for enhancing chemosensitivity
por: Zhang, Yuan, et al.
Publicado: (2009)

Spatial Separation of Plk1 Phosphorylation and Activity
por: Bruinsma, Wytse, et al.
Publicado: (2015)

Molecular dynamics of PLK1 during mitosis
por: Schmucker, Stephane, et al.
Publicado: (2014)

Multiple Roles of PLK1 in Mitosis and Meiosis
por: Kalous, Jaroslav, et al.
Publicado: (2023)

ATP-competitive Plk1 inhibitors induce caspase 3-mediated Plk1 cleavage and activation in hematopoietic cell lines
por: Dufies, Maeva, et al.
Publicado: (2017)

Study of the mechanism by which dinaciclib induces apoptosis and cell cycle arrest of lymphoma Raji cells through a CDK1‐involved pathway
por: Zhao, Huayan, et al.
Publicado: (2019)

Tumor Suppressor PLK2 May Serve as a Biomarker in Triple-Negative Breast Cancer for Improved Response to PLK1 Therapeutics
por: Gao, Yang, et al.
Publicado: (2021)

Asterless amplifies Plk4
por: Short, Ben
Publicado: (2015)

PLK1 Down-Regulates Parainfluenza Virus 5 Gene Expression
por: Sun, Dengyun, et al.
Publicado: (2009)

Aurora borealis wraps Plk1 and CDK together
por: Mochida, Satoru
Publicado: (2014)

PLK-1 Targeted Inhibitors and Their Potential against Tumorigenesis
por: Kumar, Shiv, et al.
Publicado: (2015)

PLK1, A Potential Target for Cancer Therapy
por: Liu, Zhixian, et al.
Publicado: (2016)

Re-investigating PLK1 inhibitors as antimitotic agents
por: Delacour, Quentin, et al.
Publicado: (2017)

Gravin regulates centrosome function through PLK1
por: Colicino, Erica G., et al.
Publicado: (2018)

Expression of FOXM1 and PLK1 predicts prognosis of patients with hepatocellular carcinoma
por: Fan, Weiqiang, et al.
Publicado: (2022)

Xanthatin Selectively Targets Retinoblastoma by Inhibiting the PLK1-Mediated Cell Cycle
por: Yang, Jie, et al.
Publicado: (2021)

Plk1 promotes renal tubulointerstitial fibrosis by targeting autophagy/lysosome axis
por: Du, Yang, et al.
Publicado: (2023)

Mechanisms Underlying Plk1 Polo-Box Domain-Mediated Biological Processes and Their Physiological Significance
por: Lee, Kyung S., et al.
Publicado: (2014)

Plk2-mediated phosphorylation and translocalization of Nrf2 activates anti-inflammation through p53/Plk2/p21(cip1) signaling in acute kidney injury
por: Kim, Da-Eun, et al.
Publicado: (2022)

Plk4/SAK/ZYG-1 in the regulation of centriole duplication
por: Pearson, Chad G, et al.
Publicado: (2010)

Multiple Requirements of PLK1 during Mouse Oocyte Maturation
por: Solc, Petr, et al.
Publicado: (2015)

Exploration of the Combination of PLK1 Inhibition with Immunotherapy in Cancer Treatment
por: Li, Mengyuan, et al.
Publicado: (2018)

Regulatory functional territory of PLK-1 and their substrates beyond mitosis
por: Kumar, Shiv, et al.
Publicado: (2017)

Combinatorial Effect of PLK1 Inhibition with Temozolomide and Radiation in Glioblastoma
por: Pandey, Arvind, et al.
Publicado: (2021)

PLK1 inhibition-based combination therapies for cancer management
por: Su, Shengqin, et al.
Publicado: (2021)

Present and Future Perspective on PLK1 Inhibition in Cancer Treatment
por: Chiappa, Michela, et al.
Publicado: (2022)

The dark side of PLK1: Implications for cancer and genomic instability
por: Gheghiani, Lilia, et al.
Publicado: (2023)

Upregulation of PAIP1 promotes the gallbladder tumorigenesis through regulating PLK1 level
por: Bi, Jianping, et al.
Publicado: (2021)

The FOXM1-PLK1 axis is commonly upregulated in oesophageal adenocarcinoma
por: Dibb, M, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_24npem908urt5b69njot2q3689